Home / NTRB : NASDAQ

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does NTRB make money? Does NTRB have pricing power? What's the Earnings Whisper? Will NTRB profit more as the business scales? What is NTRB's management track record? Is NTRB's current price justified?

Nutriband Inc.

$6.94 +$2.51 (+56.72%)

NASDAQ · 14 Sep 2026 13:57 UTC

Previous Close

$6.96

Day Range

$6.56$7

Year Range

$2.8$8.63

Market Cap

84.4M

AVG Volume

22.03K

Trailing/Forward PE

-12.05/1.9

PEG ratio

-0.09

Dividend Yield

Next Earnings Date

2026-12-07

Primary Exchange

NASDAQ

Revenue (USD)

NTRB Revenue (USD) by quarter
Period	Revenue (USD)
26 Q2	437.51K
26 Q1	433.4K
25 Q4	400.71K
25 Q3	346.06K
25 Q2	622.45K
25 Q1	667.43K
24 Q4	642.38K
24 Q3	645.8K
24 Q2	442.83K
24 Q1	408.53K

Net Income (USD)

NTRB Net Income (USD) by quarter
Period	Net Income (USD)
26 Q2	-880.56K
26 Q1	-1.24M
25 Q4	-968.06K
25 Q3	-3.87M
25 Q2	-2M
25 Q1	-1.39M
24 Q4	-5.52M
24 Q3	-1.36M
24 Q2	-1.71M
24 Q1	-1.9M

Operating Income (USD)

NTRB Operating Income (USD) by quarter
Period	Operating Income (USD)
26 Q2	-890.64K
26 Q1	-1.25M
25 Q4	-1.02M
25 Q3	-3.88M
25 Q2	-2M
25 Q1	-1.41M
24 Q4	-1.96M
24 Q3	-1.43M
24 Q2	-1.41M
24 Q1	-1.89M

EBITDA (USD)

NTRB EBITDA (USD) by quarter
Period	EBITDA (USD)
26 Q2	-857.31K
26 Q1	-1.2M
25 Q4	-926.85K
25 Q3	-3.82M
25 Q2	-1.94M
25 Q1	-1.33M
24 Q4	-5.44M
24 Q3	-1.28M
24 Q2	-1.63M
24 Q1	-1.82M

Cash Flows (USD)

NTRB Cash Flows (USD) by quarter
Period	Cash Flows (USD)
26 Q2	-585K
26 Q1	-563.1K
25 Q4	-731.83K
25 Q3	-1.75M
25 Q2	-1.31M
25 Q1	-1.34M
24 Q4	-1.24M
24 Q3	-1.06M
24 Q2	-1.58M
24 Q1	-840.12K

EPS (USD)

NTRB EPS (USD) by quarter
Period	EPS (USD)
26 Q2	-0.07
26 Q1	-0.1
25 Q4	-0.08
25 Q3	-0.32
25 Q2	-2.12
25 Q1	-0.12
24 Q4	-0.51
24 Q3	-0.12
24 Q2	-0.15
24 Q1	-0.21

Expenses (USD)

NTRB Expenses (USD) by quarter
Period	Expenses (USD)
26 Q2	1.07M
26 Q1	1.45M
25 Q4	1.11M
25 Q3	3.95M
25 Q2	2.15M
25 Q1	1.67M
24 Q4	2.24M
24 Q3	1.65M
24 Q2	1.54M
24 Q1	2.05M

Cash & Debt (USD)

NTRB Cash & Debt (USD) by quarter
Period	Cash & Debt (USD)
26 Q2	3.42M
26 Q1	4.01M
25 Q4	4.57M
25 Q3	5.31M
25 Q2	7M
25 Q1	2.96M
24 Q4	4.31M
24 Q3	5.7M
24 Q2	6.76M
24 Q1	8.35M

Debt ratios

NTRB Debt ratios by quarter
Period	Debt ratios
26 Q2	0.47
26 Q1	0.48
25 Q4	0.54
25 Q3	0.41
25 Q2	0.67
25 Q1	0.28
24 Q4	0.41
24 Q3	0.84
24 Q2	0.95
24 Q1	1.3

Margins

NTRB Margins by quarter
Period	Margins
26 Q2	41.57%
26 Q1	45.41%
25 Q4	22.2%
25 Q3	19.8%
25 Q2	25.2%
25 Q1	37.75%
24 Q4	42.75%
24 Q3	27.82%
24 Q2	20.51%
24 Q1	37.75%

Return on Capital

NTRB Return on Capital by quarter
Period	Return on Capital
26 Q2	-16.52%
26 Q1	-20.73%
25 Q4	-14.49%
25 Q3	-51.3%
25 Q2	-23.55%
25 Q1	-27.22%
24 Q4	-85.8%
24 Q3	-12.13%
24 Q2	-13.68%
24 Q1	-14.2%

Shares Outstanding

NTRB Shares Outstanding by quarter
Period	Shares Outstanding
26 Q2	12.16M
26 Q1	12.16M
25 Q4	12.16M
25 Q3	12.06M
25 Q2	11.22M
25 Q1	11.13M
24 Q4	10.61M
24 Q3	11.1M
24 Q2	11.06M
24 Q1	9.16M

Book Value Per Share (USD)

NTRB Book Value Per Share (USD) by quarter
Period	Book Value Per Share (USD)
26 Q2	0.44
26 Q1	0.49
25 Q4	0.55
25 Q3	0.63
25 Q2	0.76
25 Q1	0.46
24 Q4	0.61
24 Q3	1.01
24 Q2	1.13
24 Q1	1.46

Total Assets (USD)

NTRB Total Assets (USD) by quarter
Period	Total Assets (USD)
26 Q2	6.29M
26 Q1	6.89M
25 Q4	7.55M
25 Q3	8.42M
25 Q2	10.18M
25 Q1	6.15M
24 Q4	7.47M
24 Q3	12.54M
24 Q2	13.63M
24 Q1	15.15M

Employee Count

NTRB Employee Count by quarter
Period	Employee Count
2026	500
2025	2.02K
2024	2.02K
2022	13
2021	13
2019	7
2018	150
2017	150

Free Cash Flow Yield

NTRB Free Cash Flow Yield by quarter
Period	Free Cash Flow Yield
Sep 26	-4.29%
Sep 26	-5.01%
Aug 26	-8.03%
Aug 26	-7.67%
Aug 26	-10.86%
Aug 26	-11.52%
Jul 26	-12.57%
Jul 26	-12.02%
Jul 26	-11.52%
Jul 26	-12.1%
Jul 26	-11.71%
Jun 26	-11.71%
Jun 26	-12.36%
Jun 26	-10.57%
Jun 26	-11.79%
May 26	-12.09%
May 26	-11.59%
May 26	-11.72%
May 26	-11.25%
May 26	-10.93%
Apr 26	-11.69%
Apr 26	-10.87%
Apr 26	-11.99%
Apr 26	-12.88%
Mar 26	-12.11%
Mar 26	-12.67%
Mar 26	-12.53%
Mar 26	-10.72%
Feb 26	-10.53%
Feb 26	-10.55%
Feb 26	-11.37%
Feb 26	-10.75%
Jan 26	-9.76%
Jan 26	-9.74%
Jan 26	-10.72%
Jan 26	-10.7%
Jan 26	-10.55%
Dec 25	-9.74%
Dec 25	-10.41%
Dec 25	-9.17%
Dec 25	-9.14%
Nov 25	-8.9%
Nov 25	-9.21%
Nov 25	-8.01%
Nov 25	-7.3%
Oct 25	-6.54%
Oct 25	-6.16%
Oct 25	-5.89%
Oct 25	-5.86%
Oct 25	-5.93%
Sep 25	-6.07%
Sep 25	-6.1%
Sep 25	-6.16%
Sep 25	-7.35%
Aug 25	-7.25%
Aug 25	-7.28%
Aug 25	-7.14%
Aug 25	-6.54%
Aug 25	-6.34%
Jul 25	-5.5%
Jul 25	-5.78%
Jul 25	-5.89%
Jul 25	-4.73%
Jun 25	-5.87%
Jun 25	-6.02%
Jun 25	-6.56%
Jun 25	-6.09%
May 25	-7.21%
May 25	-8.12%
May 25	-7.92%
May 25	-7.78%
May 25	-6.98%
Apr 25	-7.19%
Apr 25	-7.58%
Apr 25	-8.1%
Apr 25	-7.08%
Mar 25	-6.11%
Mar 25	-5.68%
Mar 25	-6.17%
Mar 25	-5.88%
Feb 25	-5.26%
Feb 25	-5.13%
Feb 25	-5.37%
Feb 25	-4.9%
Jan 25	-4.61%
Jan 25	-4.48%
Jan 25	-9.31%
Jan 25	-9.26%
Jan 25	-7.55%
Dec 24	-9.94%
Dec 24	-9.38%
Dec 24	-9.24%
Dec 24	-9.29%
Nov 24	-8.01%
Nov 24	-8%
Nov 24	-8.13%
Nov 24	-7.22%
Nov 24	-6.49%
Oct 24	-6.7%
Oct 24	-5.87%

Price to Sales

NTRB Price to Sales by quarter
Period	Price to Sales
Sep 26	52.3
Sep 26	44.86
Aug 26	30.08
Aug 26	31.49
Aug 26	22.25
Aug 26	20.97
Jul 26	19.22
Jul 26	20.1
Jul 26	20.97
Jul 26	19.96
Jul 26	20.64
Jun 26	20.64
Jun 26	19.56
Jun 26	22.86
Jun 26	21.37
May 26	20.83
May 26	21.73
May 26	21.49
May 26	22.38
May 26	23.04
Apr 26	21.17
Apr 26	22.76
Apr 26	20.64
Apr 26	19.21
Mar 26	20.43
Mar 26	19.53
Mar 26	19.74
Mar 26	23.07
Feb 26	23.5
Feb 26	23.44
Feb 26	21.75
Feb 26	23.02
Jan 26	25.35
Jan 26	25.4
Jan 26	23.07
Jan 26	23.13
Jan 26	23.44
Dec 25	25.4
Dec 25	23.76
Dec 25	26.99
Dec 25	20.97
Nov 25	21.54
Nov 25	20.8
Nov 25	23.93
Nov 25	26.24
Oct 25	29.29
Oct 25	31.11
Oct 25	32.55
Oct 25	32.68
Oct 25	32.33
Sep 25	31.59
Sep 25	31.42
Sep 25	31.11
Sep 25	29.6
Aug 25	30.01
Aug 25	29.87
Aug 25	30.48
Aug 25	33.26
Aug 25	34.28
Jul 25	39.57
Jul 25	37.62
Jul 25	36.92
Jul 25	45.97
Jun 25	37.02
Jun 25	36.14
Jun 25	33.17
Jun 25	35.72
May 25	30.15
May 25	27.17
May 25	27.86
May 25	28.36
May 25	31.58
Apr 25	29.21
Apr 25	27.73
Apr 25	25.92
Apr 25	29.65
Mar 25	34.38
Mar 25	36.96
Mar 25	34.05
Mar 25	35.75
Feb 25	39.92
Feb 25	40.96
Feb 25	39.1
Feb 25	42.89
Jan 25	45.52
Jan 25	46.84
Jan 25	22.57
Jan 25	22.68
Jan 25	27.84
Dec 24	21.14
Dec 24	22.4
Dec 24	22.73
Dec 24	22.62
Nov 24	29.44
Nov 24	29.5
Nov 24	29.01
Nov 24	32.69
Nov 24	36.37
Oct 24	35.2
Oct 24	40.17

Price to Book

NTRB Price to Book by quarter
Period	Price to Book
Sep 26	15.88
Sep 26	13.62
Aug 26	9.05
Aug 26	9.48
Aug 26	6.7
Aug 26	6.31
Jul 26	5.78
Jul 26	6.05
Jul 26	6.31
Jul 26	6.01
Jul 26	6.21
Jun 26	6.21
Jun 26	5.89
Jun 26	6.88
Jun 26	6.52
May 26	6.35
May 26	6.62
May 26	6.55
May 26	6.82
May 26	7.02
Apr 26	6.39
Apr 26	6.87
Apr 26	6.23
Apr 26	5.8
Mar 26	6.17
Mar 26	5.89
Mar 26	5.96
Mar 26	6.96
Feb 26	7.09
Feb 26	7.08
Feb 26	6.56
Feb 26	6.95
Jan 26	7.65
Jan 26	7.67
Jan 26	6.96
Jan 26	6.98
Jan 26	7.08
Dec 25	7.67
Dec 25	7.17
Dec 25	8.15
Dec 25	6.37
Nov 25	6.54
Nov 25	6.31
Nov 25	7.26
Nov 25	7.96
Oct 25	8.89
Oct 25	9.44
Oct 25	9.88
Oct 25	9.92
Oct 25	9.81
Sep 25	9.59
Sep 25	9.54
Sep 25	9.44
Sep 25	13.91
Aug 25	14.11
Aug 25	14.04
Aug 25	14.32
Aug 25	15.63
Aug 25	16.11
Jul 25	18.6
Jul 25	17.68
Jul 25	17.35
Jul 25	21.61
Jun 25	17.4
Jun 25	16.98
Jun 25	15.59
Jun 25	16.79
May 25	14.17
May 25	9.04
May 25	9.27
May 25	9.44
May 25	10.51
Apr 25	5.26
Apr 25	4.99
Apr 25	4.67
Apr 25	5.34
Mar 25	6.19
Mar 25	6.65
Mar 25	6.13
Mar 25	6.43
Feb 25	7.19
Feb 25	7.37
Feb 25	7.04
Feb 25	7.72
Jan 25	8.19
Jan 25	8.43
Jan 25	4.06
Jan 25	4.08
Jan 25	5.01
Dec 24	3.81
Dec 24	4.03
Dec 24	4.09
Dec 24	4.07
Nov 24	4.26
Nov 24	4.27
Nov 24	4.2
Nov 24	4.73
Nov 24	5.26
Oct 24	5.1
Oct 24	5.81

No video analysis for this stock yet. Request one from our team.

News: NTRB

globenewswire.com · 9 Sep 2026

Nutriband CEO, Gareth Sheridan to Attend the Nasdaq Life Sciences Advisory Board (LaB) Biotech Summit

ORLANDO, Fla., Sept. 09, 2026 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), today announced that its CEO, Gareth Sheridan will attend the inaugural Nasdaq LaB Biotech Summit on September 16th.

globenewswire.com · 8 Sep 2026

Nutriband Receives USPTO Notice of Publication of Commercial Brand Name Trademarks for Its Abuse Deterrent Fentanyl Patch

Nutriband has received a Notice of Publication from the United States Patent and Trademark Office (USPTO) for commercial brand name trademarks for its lead product, an abuse deterrent fentanyl transdermal system. Once allowed, Nutriband plans to submit its commercial worldwide brand name to the FDA and other international regulatory agencies for approval.

globenewswire.com · 13 Aug 2026

Nutriband CEO, Gareth Sheridan to Present at the 2026 Georgia Life Sciences Summit as Part of the CEO Spotlight

ORLANDO, Fla., Aug. 13, 2026 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), today announced that its CEO and Co-Founder, Gareth Sheridan will present at the 2026 Georgia Life Sciences Summit on Aug 26th as part of the CEO spotlight event.